Nicola Dagg > Kirkland & Ellis International LLP > London, England > Lawyer Profile
Kirkland & Ellis International LLP Offices
30 ST MARY AXE
LONDON
EC3A 8AF
England
- Firm Profile
- Go to...
Nicola Dagg
Work Department
Intellectual Property Litigation
Position
Nicola Dagg is a partner in the IP litigation team in the London office of Kirkland & Ellis International LLP. Nicola’s practice spans four areas: (1) strategic life sciences patent and product lifecycle advice; (2) patent litigation; (3) co-ordinating global IP enforcement/defence cases; and (4) standard essential patent (SEP) and FRAND disputes. Nicola has tried over 20 cases.
Nicola has extensive experience in pharmaceutical and biologics patent litigation including blockbuster small molecule litigation against generic companies, biologics and biosimilar litigation, antibodies, immunotherapies, genetics, vaccines, diagnostics and gene therapies. Nicola also acts in market leading SEP essentiality, validity and global FRAND adjudication litigation in the tech sector. Having served as UK and European/global co-ordinating counsel for numerous strategic IP litigation cases and drawing on more than 24 years of legal, IP, life sciences and tech experience she helps clients solve their most pressing global challenges.
Career
2018 to present Kirkland & Ellis International LLP; 2006-2018 Allen & Overy LLP; 1996-2006 Hogan Lovells
Education
Newnham College, University of Cambridge (M.A. Natural Sciences 1991); University of Bristol (Diploma in Intellectual Property Law and Practice 1997)
Lawyer Rankings
London > Industry focus > Life sciences and healthcare
(Leading individuals)Kirkland & Ellis International LLP houses a ‘talented and experienced‘ team, which is noted for its strength in IP disputes, follow on damages cases, and M&A. Daniel Lim, ‘titan of IP litigation‘ Nicola Dagg, and Emma Flett jointly lead the practice. ‘Top-class litigator‘ Lim acts for a clients in disputes concerning medical devices and pharmaceutical products, often in relation to commercial launches and injunctions. Hailed by clients as ‘one of the outstanding patent litigators of current times‘, Dagg regularly defends patents against challenges from generics manufacturers. Litigator Jin Ooi has broad expertise in small molecule, DNA sequencing, and transgenic animal platform issues, displaying ‘laser sharp focus‘ when arbitrating trade secrets disputes in the medical devices space. Since publication, Katie Coltart has moved to Linklaters LLP.
London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
(Hall of Fame)‘Top-class’ Kirkland & Ellis International LLP maintains a strong IP offering, routinely handling high-stakes disputes, one notable example being the team’s representation of Pfizer and Regeneron in landmark judgments in the Supreme Court. The team of ‘ferocious litigators’ also has experience of handling SEP/FRAND related litigation. On the transactional side, the team is involved in M&A deals, as well as multiple asset deals and carve-out transactions. Nicola Dagg spearheads the IP litigation practice, she has a wealth of experience in managing biotech patent litigations, as well as an expertise in emerging SEP/FRAND related work. Daniel Lim is noted for his ability to handle complex multijurisdictional patent litigation, often involving blockbuster life sciences and medical devices related matters, while IP litigator Steven Baldwin is well-versed in the high-tech and life sciences sectors. ‘Strategic thinker’ Jin Ooi fields a strong IP litigation practice, with his expertise in the biotechnology space. Emma Flett leads the firm’s technology and IP transactions team with her capabilities that encompass the full gamut of IP-related work, but especially in regard to high-value M&A transactions.
Lawyer Rankings
- Hall of Fame London > TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Intellectual property: patents (contentious and non-contentious) London > TMT (technology, media and telecoms)
- Leading individuals London > Industry focus > Life sciences and healthcare
- Life sciences and healthcare London > Industry focus
Top Tier Firm Rankings
- Finance > Acquisition finance
- Finance > Corporate restructuring & insolvency
- Finance > High yield
- Projects, energy and natural resources > Infrastructure: M&A and acquisition financing
- TMT (technology, media and telecoms) > Intellectual property: patents (contentious and non-contentious)
- Crime, fraud and licensing > Fraud: white-collar crime (advice to individuals)
- Corporate and commercial > M&A: Upper Mid-Market And Premium Deals, £750m+
- Corporate and commercial > Private equity: transactions – high-value deals (£250m+)
- Investment fund formation and management > Private funds
- Investment fund formation and management > Real estate funds
Firm Rankings
- Corporate and commercial > Corporate tax
- Investment fund formation and management > Fund finance
- Real estate > Property finance
- Risk advisory > Regulatory investigations and corporate crime (advice to corporates)
- Corporate and commercial > EU and competition
- Corporate and commercial > Financial services: non-contentious/regulatory
- Dispute resolution > International arbitration
- Industry focus > Life sciences and healthcare
- Corporate and commercial > Financial services: contentious
- Dispute resolution > Commercial litigation: premium